Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
30.78
-0.02 (-0.06%)
Dec 20, 2024, 4:00 PM EST - Market closed
Edgewise Therapeutics Employees
Edgewise Therapeutics had 88 employees as of December 31, 2023. The number of employees increased by 29 or 49.15% compared to the previous year.
Employees
88
Change (1Y)
29
Growth (1Y)
49.15%
Revenue / Employee
n/a
Profits / Employee
-$1,412,432
Market Cap
2.91B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 88 | 29 | 49.15% |
Dec 31, 2022 | 59 | 28 | 90.32% |
Dec 31, 2021 | 31 | 12 | 63.16% |
Dec 31, 2020 | 19 | - | - |
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
QuidelOrtho | 7,100 |
Zai Lab | 2,175 |
iRhythm Technologies | 2,000 |
Twist Bioscience | 923 |
ACADIA Pharmaceuticals | 598 |
Amicus Therapeutics | 517 |
Xenon Pharmaceuticals | 259 |
EWTX News
- 5 days ago - Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease - Benzinga
- 5 days ago - Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker) - Business Wire
- 16 days ago - Edgewise Provides Statement Regarding Company's Relationship with Dr. Han Phan at Rare Disease Research - Business Wire
- 25 days ago - Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024 - Business Wire
- 6 weeks ago - Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Business Wire
- 2 months ago - Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society - Business Wire
- 2 months ago - Analysts Think There's Still Time To Get In On Edgewise - Benzinga
- 3 months ago - Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge - Benzinga